Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 4114) is a clinical research site located in New Haven, Connecticut, United States 06511.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 4114) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Endometrial Cancer.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 4114) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 4114) has 1 clinical trials on record, with 1 currently active. Their work covers Endometrial Cancer.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 4114) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.